Commons Sense

House of Commons · Ministers' Questions

Covid-19: Vaccine

Tuesday 23 June 2020 · 1 question

Summarised by AI from the official record, so it can contain mistakes.

Read the full transcript on Parliament.uk

At a glance

Answered 1 Partly answered 0 Not answered 0

Key points

  • UK Department is supporting vaccine development for COVID-19 through funding and other means
  • Human clinical trials are currently underway at the University of Oxford and Imperial College London
  • Vaccine rollout will be coordinated across the UK to ensure access based on clinical need

Topics (select to filter)

Questions & Answers

Q1 Craig Williams Con Montgomeryshire
NHS
Context

Discussion on the progress of vaccine development for COVID-19, including clinical trials by UK institutions.

Question

What steps is his Department taking to support the development of a vaccine for COVID-19? Additionally, can he reassure that if a vaccine is developed, it will be rolled out in a partnership across the UK and ensure access for people in devolved healthcare systems according to clinical need?

Answer from The Secretary of State for Health and Social Care Matthew Hancock

Vaccine development is progressing well with human clinical trials underway by the University of Oxford and Imperial College London. The vaccine programme will be taken forward on a UK-wide basis to ensure people living in devolved nations have access according to clinical priority, not based on location.

Answered
Was this summary accurate? Tell us

How accurate was this summary? (1 = poor, 5 = spot on)

Get updates like this by email